MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 20, 2005; DOI: 10.1124/mol.104.010850


0026-895X/05/6804-1142-1147$20.00
Mol Pharmacol 68:1142-1147, 2005

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.010850v1
68/4/1142    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamura, H.
Right arrow Articles by Shimada, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamura, H.
Right arrow Articles by Shimada, S.

Icilin Activates the {delta}-Subunit of the Human Epithelial Na+ Channel

Hisao Yamamura, Shinya Ugawa, Takashi Ueda, Masataka Nagao, and Shoichi Shimada

Departments of Molecular Morphology (H.Y., S.U., T.U., S.S.) and Forensic Medical Science (M.N.), Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan

Received December 26, 2004; accepted July 20, 2005


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
The amiloride-sensitive epithelial Na+ channel (ENaC) regulates Na+ homeostasis in cells and across epithelia. Four homologous ENaC subunits ({alpha}, {beta}, {gamma}, and {delta}) have been isolated in mammals. The chemical activators acting on ENaC, however, are largely unknown. More recently, we have found that capsazepine activates human ENaC{delta} (hENaC{delta}), which is mainly expressed in the brain. In addition, here we show that icilin, which is a tetrahydropyrimidine-2-one derivative unrelated structurally to capsazepine, markedly enhanced the activity of hENaC{delta}{beta}{gamma} heteromultimer expressed in Xenopus laevis oocytes. The inward currents at a holding potential of -60 mV in hENaC{delta}{beta}{gamma}-expressing oocytes were increased by the application of icilin in a concentration-dependent manner with an EC50 value of 33 µM. The icilin-elicited current was mostly abolished by the addition of 100 µM amiloride or by the removal of external Na+. Homomeric hENaC{delta} was also significantly activated by icilin, whereas hENaC{alpha} activity was not affected by icilin, and icilin caused a slight inhibition of the hENaC{alpha}{beta}{gamma} current. Furthermore, icilin acted together with protons or capsazepine on hENaC{delta}{beta}{gamma}. These findings identify icilin as a novel chemical activator of ENaC{delta}, providing us with a lead compound for drug development in the degenerin/ENaC superfamily.


The degenerin/epithelial Na+ channel superfamily has striking functional diversity, including Na+ homeostasis, acid sensing, peptide-gating, acidosis-evoked nociception, and mechanotransduction (Ugawa et al., 1998Go, 2002Go; Alvarez de la Rosa et al., 2000Go; Kellenberger and Schild, 2002Go; Welsh et al., 2002Go). The amiloride-sensitive epithelial Na+ channel (ENaC) is an essential control element for Na+ transport into cells and across epithelia. Four homologous ENaC subunits ({alpha}, {beta}, {gamma}, and {delta}) have been cloned in mammals (Canessa et al., 1993Go, 1994Go; McDonald et al., 1994Go, 1995Go; Waldmann et al., 1995Go). The {delta}-subunit was originally described to be expressed mainly in the human brain (Waldmann et al., 1995Go), and we have demonstrated that protons activate ENaC{delta} (Yamamura et al., 2004bGo). To explore physiological functions of ENaC{delta} in the human brain, it is necessary to identify the chemical modulator for ENaC{delta}. In pharmacological profiles of ENaC{delta}, it is well-published that the potassium-sparing diuretics, amiloride and benzamil, inhibit the activities of ENaC{delta} homomer and the heteromeric complexes with {beta} and {gamma} subunits (Waldmann et al., 1995Go; Ji et al., 2004Go). More recently, we have shown that capsazepine, which was originally developed as a competitive antagonist for transient receptor potential vanilloid subfamily 1 (Bevan et al., 1992Go; Szallasi et al., 1993Go; Caterina et al., 1997Go; Szallasi and Blumberg, 1999Go), is the first known chemical activator of ENaC{delta} (Yamamura et al., 2004aGo).

In this investigation, the effects of icilin, which is a tetrahydropyrimidine-2-one derivative (Wei and Seid, 1983Go) and is also an activator for transient receptor potential melastatin subfamily 8 and ankyrin-like subfamily 1 (McKemy et al., 2002Go; Story et al., 2003Go; Andersson et al., 2004Go; Chuang et al., 2004Go), were examined on the human ENaC (hENaC) current using electrophysiological analyses in the Xenopus laevis oocyte expression system. Here, we show that icilin activates hENaC{delta}{beta}{gamma} in a concentration-dependent manner, and the icilin-evoked current was influenced by amiloride or external Na+ removal. Icilin activated the hENaC{delta} homomer as well as hENaC{delta}{beta}{gamma}, whereas the hENaC{alpha}{beta}{gamma} current was slightly reduced by icilin. These results indicate that icilin is a novel agonist for ENaC{delta}.


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Molecular Biology. All experiments were approved by the Ethics Committee of the Nagoya City University Graduate School of Medical Sciences and were conducted in accordance with the Declaration of Helsinki. The full-length hENaC{alpha} (GenBank accession number X76180 [GenBank] ), hENaC{beta} (X87159 [GenBank] ), hENaC{gamma} (U48937 [GenBank] ), and hENaC{delta} (U38254 [GenBank] ) were isolated from human skin (for {alpha}, {beta}, and {gamma} subunits) or brain (for {delta} subunit) cDNA, as described previously (Yamamura et al., 2004aGo).

X. laevis Oocyte Electrophysiology. Electrophysiological studies in X. laevis oocytes, using a two-electrode voltage-clamp technique, were performed as described previously (Yamamura et al., 2004aGo,bGo). In brief, cRNA transcript(s) (1 ng for homomeric channel or each 0.01 ng for coexpression) was injected into X. laevis oocytes, whereas the control oocytes were injected with an equal volume of diethyl dicarbonate-treated water, described as "native" throughout. After injection, oocytes were incubated at 20°C in a recording solution supplemented with 20 units/ml penicillin G, 20 µg/ml streptomycin, and either 10 (for hENaC{alpha} and {alpha}{beta}{gamma}) or 100 µM (for hENaC{delta} and {delta}{beta}{gamma}) amiloride for 24 to 48 h before electrophysiological recordings. The recording solution had an ionic composition of 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, and 5 mM HEPES. The pH of the solution was adjusted to 7.5 with NaOH. The external Na+-free solution was prepared by the replacement of 96 mM Na+ with the equivalent N-methyl-D-glucamine (NMDG). All electrophysiological recordings were performed at a holding potential of -60 mV. The current-voltage relationships were measured using a ramp protocol from -100 to 50 mV for 30 s. The recording chamber was continuously perfused with solution at a flow rate of 5 ml/min. All electrophysiological experiments were carried out at room temperature (25 ± 1°C).

Drugs. Pharmacological reagents were obtained from Sigma Chemical (St. Louis, MO). Icilin was dissolved in dimethyl sulfoxide at the concentration of 100 mM as a stock solution. It was confirmed that up to 1% of dimethyl sulfoxide did not affect the oocyte currents.

Statistics. Pooled data are shown as the mean ± S.E. Statistical significance between two groups and among groups was determined by Student's t test and Scheffé's test after one-way analysis of variance, respectively. Significant difference is expressed in the figures (** or ##, p < 0.01). The data of the relationship between icilin concentrations and current responses were fitted using the following equation after normalization by the current amplitude in the absence of icilin (Figs. 4B and 5): IIcilin/IControl = (Imax/IContol)/{1 + (Kd/[Icilin])n}, where Imax is the maximum amplitude of the icilin-evoked current, Kd is the apparent dissociation constant of icilin, [Icilin] is the concentration of icilin, and n is the Hill coefficient.



View larger version (14K):
[in this window]
[in a new window]
 
Fig. 4. Dose-dependence of current activation by icilin. The dependence on icilin concentration of the hENaC{delta}{beta}{gamma} current was analyzed in X. laevis oocytes. A, a typical current trace of icilin responsiveness from 1 to 1000 µM in an hENaC{delta}{beta}{gamma}-injected oocyte is represented. The activation of an inward current by icilin was observed in a concentration-dependent manner. B, icilin sensitivity in hENaC{delta}{beta}{gamma} currents is plotted. The icilin-induced current was normalized by the current amplitude in the absence of icilin. The inward current was significantly potentiated by icilin at a concentration of 10 µM and more in hENaC{delta}{beta}{gamma}-expressed oocytes (p < 0.01). The EC50 value for icilin on the inward currents was 33 ± 1 µM, and the Hill coefficient was 1.3 ± 0.1. Experimental data were obtained from five oocytes.

 


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 5. Sensitization by protons and capsazepine on icilin-activated hENaC{delta}{beta}{gamma} current. The effects of protons and capsazepine on the icilin-activated hENaC{delta}{beta}{gamma} current in X. laevis oocytes were examined. A, in hENaC{delta}{beta}{gamma}-injected oocytes, the decrease in pH from 7.5 to 7.0, which is the subthreshold concentration of protons on the hENaC{delta}{beta}{gamma} current, caused a leftward shift of the dose-response curve for icilin on the inward current to an EC50 value of 16 ± 2 µM and a Hill coefficient of 1.2 ± 0.1. B, in the presence of 1 µM capsazepine, which by itself had a very small effect on hENaC{delta}{beta}{gamma} current, the dose-response curve for icilin on inward currents was shifted to the left with an EC50 value of 12 ± 1 µM and a Hill coefficient of 1.2 ± 0.1. The icilin-induced current was normalized by the current amplitude in the absence of icilin. The broken line indicates a dose-response curve of icilin alone on the inward current obtained from Fig. 4B. Experimental data were obtained from five oocytes for each.

 

    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Activation of hENaC{delta}{beta}{gamma} Current by Icilin. The effects of icilin, a class of compounds known as tetrahydropyrimidine-2-one derivatives (Wei and Seid, 1983Go), on the hENaC{delta}{beta}{gamma} current were examined using a two-electrode voltage-clamp technique in the X. laevis oocyte expression system. When the hENaC{delta}{beta}{gamma} heteromultimer was expressed in X. laevis oocytes, an inward current was induced at a holding potential of -60 mV, and the current was mostly blocked by 100 µM amiloride (Fig. 1A). The mean amplitude of the amiloride-sensitive current in hENaC{delta}{beta}{gamma}-expressing oocytes was 575 ± 27 nA (n = 29, p < 0.01 versus native of 3 ± 1 nA, n = 6). In hENaC{delta}{beta}{gamma}-injected oocytes, the application of 100 µM icilin was markedly increased in the inward current (1.79 ± 0.04-fold, n = 23, p < 0.01; Fig. 1C). The current increase by icilin was recovered to the resting level by the removal of icilin in all hENaC{delta}{beta}{gamma}-expressing oocytes tested (n = 15). After washout for a few minutes, readministration of icilin caused current activation with a similar amplitude and kinetics to the first challenge (n = 6). The current-voltage relationship showed that the application of 100 µM icilin potentiated channel activity at all voltages examined in hENaC{delta}{beta}{gamma}-expressed oocytes (n = 5; Fig. 1B). On the other hand, in native oocytes, the application of 100 µM icilin did not induce any current (1.01 ± 0.01-fold, n = 6, p > 0.05).



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 1. Activation of hENaC{delta}{beta}{gamma} current by icilin. Whole-cell currents were recorded at a holding potential of -60 mV in the X. laevis oocyte expression system using a two-electrode voltage-clamp technique. A, an hENaC{delta}{beta}{gamma}-expressed oocyte possessed a larger inward current than a native oocyte. The larger current in an hENaC{delta}{beta}{gamma}-expressing oocyte was mostly inhibited by 100 µM amiloride (Ami). In an hENaC{delta}{beta}{gamma} oocyte, the application of 100 µM icilin enhanced the inward current, and this current increase was recovered by the removal of icilin. After washout for a few minutes, a readministration of icilin caused similar current activation. Note that neither the application of icilin nor amiloride induced any current in native oocytes. B, the current-voltage relationships in the absence and presence of 100 µM icilin in native and hENaC{delta}{beta}{gamma}-injected oocytes are shown. Icilin stimulus enhanced hENaC{delta}{beta}{gamma} activity at all voltages examined. C, the effects of 100 µM icilin on homomeric and heteromeric hENaCs expressed in X. laevis oocytes are summarized. The icilin-induced current was normalized by the current amplitude in the absence of icilin. The number of oocytes used is in parentheses. The statistical significance of the difference is expressed as **, p < 0.01 versus control.

 
It was examined whether the activation of the inward current by icilin was mediated though either ENaC{delta} alone or the accessory {beta} or {gamma} subunit. In homomeric hENaC{delta}-expressing oocytes, the application of 100 µM icilin significantly elicited an inward current (1.22 ± 0.03-fold, n = 5, p < 0.01; Fig. 1C), as well as in hENaC{delta}{beta}{gamma}-injected oocytes. Furthermore, we tested whether icilin was effective on another ENaC core unit, the {alpha}-subunit, in X. laevis oocytes. In contrast to hENaC{delta}- and {delta}{beta}{gamma}-injected oocytes, the application of 100 µM icilin had no effect on the inward currents in hENaC{alpha}-expressing oocytes (0.99 ± 0.01-fold, n = 8, p > 0.05), and the hENaC{alpha}{beta}{gamma} current was significantly inhibited by 100 µM icilin (0.96 ± 0.01-fold, n = 9, p < 0.01).

Effects of Amiloride on Icilin-Induced Current. To confirm whether the icilin-induced current originated from the ENaC{delta}{beta}{gamma} expression, the effects of amiloride, an inhibitor of ENaC, on the inward current in the presence of icilin were examined. The 100 µM icilin-induced current in hENaC{delta}{beta}{gamma}-injected oocytes (1421 ± 76 nA, n = 6) was dramatically inhibited by the addition of 100 µM amiloride (85 ± 3% decrease, n = 6, p < 0.01) and, moreover, significantly reduced the current to 209 ± 23 nA (n = 6, p < 0.01 versus the initial resting current of 785 ± 55 nA; Fig. 2). On the other hand, in native oocytes, the current amplitudes after the application of 100 µM icilin in the absence and presence of 100 µM amiloride (72 ± 1 and 69 ± 1 nA, respectively, n = 6) were not significant to the initial resting current (70 ± 1 nA, n = 6, p > 0.05).



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2. Effects of amiloride on icilin-induced current. The effects of amiloride on the inward current evoked by icilin were examined in X. laevis oocytes. A, a typical current trace in an hENaC{delta}{beta}{gamma}-expressing oocyte in response to icilin and amiloride (Ami) is represented. The current increase by 100 µM icilin was dramatically influenced by the addition of 100 µM amiloride. B, the effects of 100 µM icilin in native ({square}) or hENaC{delta}{beta}{gamma}-expressed ({blacksquare}) oocytes in the absence and presence of 100 µM amiloride are summarized. The application of neither icilin nor amiloride induced any current in native oocytes. Experimental data were obtained from six oocytes for each. The statistical significance of the difference is expressed as **, p < 0.01 versus control, and ##, p < 0.01 versus icilin alone.

 
Effects of External Na+ Removal on Icilin-Evoked Current. In turn, the effects of external Na+ removal were analyzed in hENaC{delta}{beta}{gamma}-expressing oocytes. The Na+-free solution was prepared by the substitution of 96 mM Na+ in recording solution with the equivalent NMDG. In the absence of external Na+, the amiloride-sensitive current was significantly small (14 ± 4 nA, n = 5, p < 0.01 versus before the removal of external Na+) (Fig. 3). The current increase by the application of 100 µM icilin was significantly reduced by the removal of external Na+ (39 ± 14 nA, n = 5, p < 0.01 versus 96 mM [Na+]o of 599 ± 23 nA, n = 5).



View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3. Effects of external Na+ removal on icilin-evoked current. The effects of external Na+ removal on the inward current elicited by icilin were examined in X. laevis oocytes. A, a typical current trace in an hENaC{delta}{beta}{gamma}-injected oocyte in response to icilin and amiloride (Ami) in the absence and presence of external Na+ is shown. The external Na+-free was prepared by the substitution of 96 mM Na+ in the recording solution with the equivalent NMDG. In the absence of external Na+, the current amplitude evoked by 100 µM icilin was smaller than that in the presence of external Na+. B, the effects of 100 µM icilin in hENaC{delta}{beta}{gamma}-expressed oocytes in the absence ({cjs2113}) and presence ({blacksquare}) of external Na+ are summarized. Experimental data were obtained from five oocytes for each. The statistical significance of the difference is expressed as **, p < 0.01 versus 96 mM [Na+]o.

 

Dose-Dependence of Current Activation by Icilin. The concentration-dependence of the icilin-induced current was examined in hENaC{delta}{beta}{gamma}-expressed oocytes. In hENaC{delta}{beta}{gamma}-expressed oocytes, changing the concentration of icilin in the range of 1 to 1000 µM showed that the inward current was significantly increased by icilin at a concentration of 10 µM and more (n = 5, p < 0.01 versus control of 743 ± 66 nA), and the enhancement was in a concentration-dependent manner (1547 ± 143 nA at 1000 µM, n = 5; Fig. 4). The EC50 value of icilin on the inward currents was 33 ± 1 µM, and the Hill coefficient was 1.3 ± 0.1 (n = 5).

Sensitization by Protons and Capsazepine on Icilin-Activated hENaC{delta}{beta}{gamma} Current. We reported previously that ENaC{delta}{beta}{gamma} activity was enhanced by external protons or capsazepine in the X. laevis oocyte expression system (Yamamura et al., 2004aGo,bGo). Therefore, the effects of icilin on the weak acidification of pH 7.0 medium, which was the subthreshold concentration of protons on hENaC{delta}{beta}{gamma} current (by 23 ± 2 nA, n = 5), were examined in hENaC{delta}{beta}{gamma}-expressed oocytes (Fig. 5A). The decrease in external pH from 7.5 to 7.0 caused a leftward shift of the dose-response curve for icilin on the inward current to the EC50 value of 16 ± 2 µM (n = 5, p < 0.01, versus pH 7.5) and the Hill coefficient of 1.2 ± 0.1. The maximum response of the icilin-induced current during the exposure to pH 7.0 (by 871 ± 144 nA, n = 5) was not statistically significant compared with that in pH 7.5 medium (by 804 ± 110 nA, n = 5, p > 0.05). On the other hand, the effects of icilin in the presence of 1 µM capsazepine, which by itself had a very small effect on hENaC{delta}{beta}{gamma} current (by 120 ± 6 nA, n = 5), were examined in hENaC{delta}{beta}{gamma}-injected oocytes (Fig. 5B). The dose-response curve for icilin on the inward currents was shifted to the left with an EC50 value of 12 ± 1 µM(n = 5, p < 0.01) and a Hill coefficient of 1.2 ± 0.1. The maximum amplitude of the icilin-evoked current in the presence of 1 µM capsazepine (by 873 ± 44 nA, n = 5) was not statistically significant compared with that in the absence of capsazepine (p > 0.05).


    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Amiloride-sensitive ENaCs, members of the degenerin/ENaC superfamily, regulate essential control elements for Na+ homeostasis in cells and across epithelia. Because the ENaC{alpha}{beta}{gamma} complex is expressed mainly in epithelia such as the kidney, lung, and colon to play a pathophysiological role, the physiological and pharmacological characterization has been well-documented (Alvarez de la Rosa et al., 2000Go; Kellenberger and Schild, 2002Go). On the other hand, the physiological function of the {delta}-subunit has not yet been identified. More recently, we have shown that ENaC{delta} is widely distributed throughout the brain and is activated by protons, indicating that it may act as a pH sensor in the human brain (Yamamura et al., 2004bGo). In addition, we have demonstrated that capsazepine is the first chemical agonist for ENaC{delta} (Yamamura et al., 2004aGo). In this investigation, we have found that the application of icilin, which is a tetrahydropyrimidine-2-one derivative unrelated structurally to capsazepine, activates hENaC{delta}{beta}{gamma} in a concentration-dependent manner, and the enhancement is sensitive to amiloride.

When the heteromultimeric hENaC{delta}{beta}{gamma} complex was expressed in X. laevis oocytes, the application of icilin at a concentration of 10 µM and more was markedly increased by an inward current. Because the icilin-induced current was significantly abolished by the addition of 100 µM amiloride, an inhibitor of ENaC, or by the removal of external Na+ in hENaC{delta}{beta}{gamma}-expressing oocytes, and icilin-elicited currents were not observed in native oocytes, the icilin-evoked currents originated from the ENaC{delta}{beta}{gamma} expression. The icilin-induced current was maintained at a steady level during icilin exposure in hENaC{delta}{beta}{gamma}-expressed oocytes (~5 min; Fig. 2A). After washout for a few minutes, the sequential challenge of icilin causes current activation to the same extent as the first trial in hENaC{delta}{beta}{gamma}-expressing oocytes. These results indicate that icilin did not induce sensitization and desensitization to the activity of hENaC{delta}{beta}{gamma} under these conditions, similarly to protons and capsazepine, which are also activators of ENaC{delta} (Ji and Benos, 2004Go; Yamamura et al., 2004aGo,bGo). In addition to the enhancement actions by icilin on transient receptor potential melastatin subfamily 8 and ankyrin-like subfamily 1 at micromolar concentrations (McKemy et al., 2002Go; Story et al., 2003Go; Andersson et al., 2004Go; Chuang et al., 2004Go), in this investigation, we clarified that icilin activates hENaC{delta}{beta}{gamma} with an EC50 of 33 µM.

The sensitivity to icilin was increased in a weak acidic medium of pH 7.0. Protons activated the hENaC{delta} current, but pH 7.0 is the subthreshold concentration of protons in the hENaC{delta}{beta}{gamma} current (Yamamura et al., 2004aGo,bGo; Ji and Benos, 2004Go). At this proton concentration, the dose-response for icilin on the inward currents was enhanced, indicating that the effect of icilin was sensitized by the addition of protons. Moreover, the concentration-dependence of hENaC{delta}{beta}{gamma} for icilin was shifted to the left by the lower concentration of capsazepine (1 µM), which by itself had a very small effect on hENaC{delta}{beta}{gamma} current (Yamamura et al., 2004aGo). Similar shifts in sensitivity by the mixture of two different ligands were observed: protons/capsaicin, capsaicin/2-aminoethoxydiphenyl borate, and protons/2-aminoethoxydiphenyl borate in transient receptor potential vanilloid subfamily 1 (Caterina et al., 1997Go; Hu et al., 2004Go) as well as protons/capsazepine in ENaC{delta}{beta}{gamma} (Yamamura et al., 2004aGo). These results indicate that icilin acts synergistically with protons or capsazepine, activating factors of ENaC{delta}. Because the structural similarity between icilin (1-(2-hydroxyphenyl)-4-(3-nitrophenyl)-1,2,3,6-tetrahydropyrimidin-2-one) and capsazepine (N-[2-(4-chlorophenyl)ethyl]-1,3,4,5-tetrahydro-7,8-dihydroxy-2H-2-benzazepine-2-carbothioamide) seemed to be low, it is still unknown whether the mechanism of channel activation by icilin is similar to that by protons or capsazepine. It is interesting that icilin, capsazepine, and protons all activate ENaC{delta} but all partially inhibit ENaC{alpha} (Chalfant et al., 1999Go; Ji and Benos, 2004Go; Yamamura et al., 2004aGo,bGo), which may be a key point for elucidating the mechanism underlying channel modulation. These findings provide useful information for drug development in the degenerin/ENaC superfamily.

Acid-sensing ion channel 1a in the central nervous system has been implicated in long-term potentiation, suggesting that minute fluxes in synaptic pH may activate a proton-sensitive channel to enhance synaptic plasticity, learning, and memory (Bianchi and Driscoll, 2002Go; Wemmie et al., 2002Go). This raises the possibility that ENaC{delta} could also play a role in learning and memory in the human brain (Yamamura et al., 2004bGo). The expressed sequence tag and genome project databases show that an ENaC{delta} gene has been found only in humans and chimpanzees (GenBank accession numbers U38254 [GenBank] and O46547 [GenBank] , respectively), and there is no evidence of the orthologs in rats and mice. The corresponding genomic assignments of ENaC{delta} were identified on human chromosome 1p36.3-p36.2 (Waldmann et al., 1996Go). Because the chemical agonists strongly influencing ENaC{delta} have been poorly investigated, icilin and capsazepine are potentially powerful tools for the electrophysiological analysis of ENaC{delta} and the elucidation of the clinical ENaC{delta} function in humans.

In conclusion, we found that icilin acts on ENaC{delta} and causes the activation of ENaC{delta}, indicating that icilin is a novel activator of ENaC{delta}. In addition to the physiological function of ENaC{delta} as a pH sensor in the human brain (Yamamura et al., 2004bGo), this finding provides a starting point for a number of exciting follow-up investigations into the physiological and pathological roles of ENaC{delta} in vitro and in vivo in humans.


    Acknowledgements
 
We thank Katsuyuki Tanaka and Kenji Kajita for technical assistance.


    Footnotes
 
This investigation was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Sciences (to H.Y. and S.S.).

Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.

doi:10.1124/mol.104.010850.

ABBREVIATIONS: ENaC, epithelial Na+ channel; h, human; NMDG, N-methyl-D-glucamine.

Address correspondence to: Dr. Hisao Yamamura, Department of Molecular Morphology, Graduate School of Medical Sciences, Nagoya City University, 1 Kawasumi Mizuhocho Mizuhoku, Nagoya 467-8601, Japan. E-mail: yamamura{at}med.nagoya-cu.ac.jp


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Alvarez de la Rosa D, Canessa CM, Fyfe GK, and Zhang P (2000) Structure and regulation of amiloride-sensitive sodium channels. Annu Rev Physiol 62: 573-594.[CrossRef][Medline]

Andersson DA, Chase HW, and Bevan S (2004) TRPM8 activation by menthol, icilin and cold is differentially modulated by intracellular pH. J Neurosci 24: 5364-5369.[Abstract/Free Full Text]

Bevan S, Hothi S, Hughes G, James IF, Rang HP, Shah K, Walpole CS, and Yeats JC (1992) Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br J Pharmacol 107: 544-552.[Medline]

Bianchi L and Driscoll M (2002) Protons at the gate: DEG/ENaC ion channels help us feel and remember. Neuron 34: 337-340.[CrossRef][Medline]

Canessa CM, Horisberger JD, and Rossier BC (1993) Epithelial sodium channel related to proteins involved in neurodegeneration. Nature (Lond) 361: 467-470.[CrossRef][Medline]

Canessa CM, Schild L, Buell G, Thorens B, Gautschi I, Horisberger JD, and Rossier BC (1994) Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature (Lond) 367: 463-467.[CrossRef][Medline]

Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, and Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (Lond) 389: 816-824.[CrossRef][Medline]

Chalfant ML, Denton JS, Berdiev BK, Ismailov II, Benos DJ, and Stanton BA (1999) Intracellular H+ regulates the {alpha}-subunit of ENaC, the epithelial Na+ channel. Am J Physiol 276: C477-C486.

Chuang HH, Neuhausser WM, and Julius D (2004) The super-cooling agent icilin reveals a mechanism of coincidence detection by a temperature-sensitive TRP channel. Neuron 43: 859-869.[CrossRef][Medline]

Hu HZ, Gu Q, Wang C, Colton CK, Tang J, Kinoshita-Kawada M, Lee LY, Wood JD, and Zhu MX (2004) 2-Aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2 and TRPV3. J Biol Chem 279: 35741-35748.[Abstract/Free Full Text]

Ji HL and Benos DJ (2004) Degenerin sites mediate proton activation of {delta}{beta}{gamma}-epithelial sodium channel. J Biol Chem 279: 26939-26947.[Abstract/Free Full Text]

Ji HL, Bishop LR, Anderson SJ, Fuller CM, and Benos DJ (2004) The role of Pre-H2 domains of {alpha}- and {delta}-epithelial Na+ channels in ion permeation, conductance and amiloride sensitivity. J Biol Chem 279: 8428-8440.[Abstract/Free Full Text]

Kellenberger S and Schild L (2002) Epithelial sodium channel/degenerin family of ion channels: a variety of functions for a shared structure. Physiol Rev 82: 735-767.[Abstract/Free Full Text]

McDonald FJ, Price MP, Snyder PM, and Welsh MJ (1995) Cloning and expression of the {beta}- and {gamma}-subunits of the human epithelial sodium channel. Am J Physiol 268: C1157-C1163.

McDonald FJ, Snyder PM, McCray PB Jr, and Welsh MJ (1994) Cloning, expression and tissue distribution of a human amiloride-sensitive Na+ channel. Am J Physiol 266: L728-L734.

McKemy DD, Neuhausser WM, and Julius D (2002) Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature (Lond) 416: 52-58.[CrossRef][Medline]

Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, Earley TJ, Hergarden AC, Andersson DA, Hwang SW, et al. (2003) ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112: 819-829.[CrossRef][Medline]

Szallasi A and Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51: 159-212.[Abstract/Free Full Text]

Szallasi A, Goso C, Blumberg PM, and Manzini S (1993) Competitive inhibition by capsazepine of [3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat. J Pharmacol Exp Ther 267: 728-733.[Abstract/Free Full Text]

Ugawa S, Minami Y, Guo W, Saishin Y, Takatsuji K, Yamamoto T, Tohyama M, and Shimada S (1998) Receptor that leaves a sour taste in the mouth. Nature (Lond) 395: 555-556.[CrossRef][Medline]

Ugawa S, Ueda T, Ishida Y, Nishigaki M, Shibata Y, and Shimada S (2002) Amiloride-blockable acid-sensing ion channels are leading acid sensors expressed in human nociceptors. J Clin Investig 110: 1185-1190.[CrossRef][Medline]

Waldmann R, Bassilana F, Voilley N, Lazdunski M, and Mattei M (1996) Assignment of the human amiloride-sensitive Na+ channel {delta} isoform to chromosome 1p36.3-p36.2. Genomics 34: 262-263.[CrossRef][Medline]

Waldmann R, Champigny G, Bassilana F, Voilley N, and Lazdunski M (1995) Molecular cloning and functional expression of a novel amiloride-sensitive Na+ channel. J Biol Chem 270: 27411-27414.[Abstract/Free Full Text]

Wei ET and Seid DA (1983) AG-3-5: a chemical producing sensations of cold. J Pharm Pharmacol 35: 110-112.[Medline]

Welsh MJ, Price MP, and Xie J (2002) Biochemical basis of touch perception: mechanosensory function of degenerin/epithelial Na+ channels. J Biol Chem 277: 2369-2372.[Free Full Text]

Wemmie JA, Chen J, Askwith CC, Hruska-Hageman AM, Price MP, Nolan BC, Yoder PG, Lamani E, Hoshi T, Freeman JH Jr, et al. (2002) The acid-activated ion channel ASIC contributes to synaptic plasticity, learning and memory. Neuron 34: 463-477.[CrossRef][Medline]

Yamamura H, Ugawa S, Ueda T, Nagao M, and Shimada S (2004a) Capsazepine is a novel activator of the {delta} subunit of the human epithelial Na+ channel. J Biol Chem 279: 44483-44489.[Abstract/Free Full Text]

Yamamura H, Ugawa S, Ueda T, Nagao M, and Shimada S (2004b) Protons activate the {delta}-subunit of the epithelial Na+ channel in humans. J Biol Chem 279: 12529-12534.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Lu, F. Echeverri, D. Kalabat, B. Laita, D. S. Dahan, R. D. Smith, H. Xu, L. Staszewski, J. Yamamoto, J. Ling, et al.
Small Molecule Activator of the Human Epithelial Sodium Channel
J. Biol. Chem., May 2, 2008; 283(18): 11981 - 11994.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Yamamura, S. Ugawa, T. Ueda, and S. Shimada
Evans Blue Is a Specific Antagonist of the Human Epithelial Na+ Channel {delta}-Subunit
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 965 - 969.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.010850v1
68/4/1142    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamura, H.
Right arrow Articles by Shimada, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamura, H.
Right arrow Articles by Shimada, S.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics